Faron Appoints Maija Hollmén PhD as CSO
Faron Pharmaceuticals Ltd. (“Faron or “Company”) Faron Appoints Maija Hollmén, Ph.D., as Chief Scientific Officer Company announcement, December 1, 2022, at 02:00 AM (EST) / 07:00 AM (GMT) / 09:00 AM (EET) TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on tackling difficult-to-treat cancers and inflammation via precision macrophage immunotherapy, today announces the appointment of Faron Co-founder Maija Hollmén, Ph.D., as Chief Scientific Officer. In her new role,